医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Relative polycythemia (Gaisbock syndrome, stress polycythemia) is apparent polycythemia from reduced plasma volume (dehydration, stress, hypertension, smoking, obesity) without true RBC-mass increase.
血液科Stress polycythemia (D75.104) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
High-altitude polycythemia (D75.103) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Acquired polycythemia (D75.102) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Transient polycythemia (D75.101) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Idiopathic thrombocytosis (D75.100x021) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Renal polycythemia (D75.100x010) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Hypoxemic polycythemia (D75.100x009) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Emotional polycythemia (D75.100x008) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
High-altitude polycythemia (D75.100x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Plasma-volume-depletion polycythemia (D75.100x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being com
Erythropoietin-mediated polycythemia (D75.100x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being com
Secondary polycythemia is RBC mass elevation from increased erythropoietin drive due to chronic hypoxemia (high altitude, smoking, lung/heart disease) or EPO-secreting tumors/renal disease. Distinct from polycythemia vera.
血液科Benign polycythemia (D75.000x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Familial polycythemia is a rare hereditary polycythemia from congenital high oxygen-affinity hemoglobin or erythropoietin-receptor mutation; RBC count/hemoglobin elevated without major symptoms.
血液科Methemoglobinemia (D74.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Toxic (acquired) methemoglobinemia is methemoglobin elevation from oxidant drugs/chemicals (nitrites, aniline, dapsone, benzocaine) oxidizing hemoglobin iron to Fe3+, causing cyanosis and tissue hypoxia.
血液科Sulfhemoglobinemia is the presence of sulfhemoglobin (sulfur-bound hemoglobin) in blood, usually from drugs (sulfonamides, dapsone, nitrites) or constipation; causes cyanosis unresponsive to methylene blue.
血液科Acquired methemoglobinemia with sulfhemoglobinemia (D74.800x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introductio
Other methemoglobinemia (D74.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|
